<p>隨着美國股市表現參差不齊，道瓊斯指數和標準普爾 500 指數出現上漲，而以科技為主的行業面臨挑戰，投資者正在探索多樣化的機會。雖然 “便士股票” 這一術語在投資中較為陳舊，但它仍然代表了一部分較小或不太成熟的公司，這些公司可能提供顯著的價值。通過關注那些財務健康且具有增長潛力的公司，投資者可以在這些鮮為人知的股票中發現有前景的機會。</p>
<h3>美國十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$1.75</td>
<td>$379.32M</td>
<td>✅ 4 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.815</td>
<td>$658.23M</td>
<td>✅ 4 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.745</td>
<td>$588.08M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.95</td>
<td>$1.2B</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Puma Biotechnology (PBYI)</td>
<td>$4.97</td>
<td>$246.41M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Performance Shipping (PSHG)</td>
<td>$2.2293</td>
<td>$27.72M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.47</td>
<td>$568.6M</td>
<td>✅ 5 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.93</td>
<td>$51.75M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.80</td>
<td>$6.53M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.775</td>
<td>$85.41M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們美國便士股票篩選器的 357 只股票的完整列表。</p>
<p>我們將查看篩選工具中一些最佳選擇。</p>
<h2>Alpha Teknova (TKNO)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Alpha Teknova, Inc. 生產用於全球新療法、疫苗和分子診斷髮現、開發和商業化的基本試劑，市值為 2.3018 億美元。</p>
<p><strong>運營：</strong> 公司的收入來自其特種化學品部門，該部門產生了 3980 萬美元的收入。</p>
<p><strong>市值：</strong> $230.18M</p>
<p>Alpha Teknova, Inc. 在便士股票市場中航行，市值為 2.3018 億美元，收入主要來自其特種化學品部門，總計 3980 萬美元。該公司保持強勁的現金狀況，覆蓋短期和長期負債，同時積極尋求收購以增強增長和盈利前景。儘管過去五年虧損不斷增加，但 Teknova 最近的財報顯示淨虧損數字較去年有所改善。預計收入將以每年 14.25% 的速度增長，儘管相對於大多數美國股票，波動性仍然較高。</p>
<ul>
<li>在我們的財務健康報告中更詳細地瞭解 Alpha Teknova 的潛力。</li>
<li>通過訪問我們的收益增長報告評估 Alpha Teknova 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a412f7f5-9a07-448c-9614-8a7f33380346/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a412f7f5-9a07-448c-9614-8a7f33380346/chart/financial-position-analysis"/></p>
<p>TKNO 財務狀況分析截至 2025 年 11 月</p>
<h2>Marqeta (MQ)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Marqeta, Inc. 運營一個基於雲的開放 API 平台，提供卡片發行和交易處理服務，市值約為 20.9 億美元。</p>
<p><strong>運營：</strong> 公司的收入來自其數據處理部門，該部門產生了 5.8856 億美元的收入。</p>
<p><strong>市值：</strong> $2.09B</p>
<p>Marqeta, Inc. 市值為 20.9 億美元，通過利用其基於雲的 API 平台進行卡片發行和交易處理，正在便士股票市場中航行。儘管處於虧損狀態，Marqeta 在五年內減少了虧損，並保持超過三年的良好現金流。該公司最近報告的第三季度銷售額為 1.6331 億美元，淨虧損顯著低於去年。與 Klarna 的卡片擴展到 15 個歐洲市場等合作，突顯了 Marqeta 的戰略合作伙伴關係和收入增長潛力，預計在 2025 年第四季度增長 22% 至 24%。</p>
<ul>
<li>點擊這裏發現 Marqeta 的細微差別，查看我們的詳細分析財務健康報告。</li>
<li>在這裏瞭解 Marqeta 未來的增長軌跡。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/financial-position-analysis"/></p>
<p>MQ 財務狀況分析截至 2025 年 11 月</p>
<h2>Hyliion Holdings (HYLN)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Hyliion Holdings Corp. 設計和開發用於靜態和移動應用的發電機，市值約為 2.9916 億美元。</p>
<p><strong>運營：</strong> Hyliion Holdings Corp. 尚未報告任何具體的收入部門。</p>
<p><strong>市值：</strong> $299.16M</p>
<p>Hyliion Holdings，市值為 2.9916 億美元，是一家專注於創新電力解決方案的無收入公司。儘管處於虧損狀態，並在 2025 年前九個月報告了 4401 萬美元的淨虧損，但它沒有債務，並保持超過一年的現金流。最近成功的 KARNO 電源模塊排放測試使 Hyliion 在清潔能源技術的前沿，可能增強其在各個行業的商業前景。然而，其高股價波動性和缺乏有意義的收入突顯了投資於此類早期階段企業的固有風險。</p>
<ul>
<li>在這裏通過我們的綜合資產負債表健康報告深入瞭解 Hyliion Holdings。</li>
<li>檢查 Hyliion Holdings 的收益增長報告，以瞭解分析師對其表現的預期。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fb9f2855-7b62-462b-bcd7-cb901c7ca573/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fb9f2855-7b62-462b-bcd7-cb901c7ca573/chart/financial-position-analysis"/></p>
<p>HYLN 財務狀況分析截至 2025 年 11 月</p>
<h2>下一步</h2>
<ul>
<li>通過使用我們的篩選器，深入瞭解所有 357 只美國便士股票。</li>
<li>想探索一些替代方案嗎？我們發現 14 只預計明年將支付超過 6% 股息收益率的美國股票。查看完整列表，免費獲取。</li>
</ul>
<p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章不應被視為財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>

HYLN

TKNO

<p>這篇文章強調了在美國股市波動中，便士股票的潛力，重點關注了 Alpha Teknova、Marqeta 和 Hyliion Holdings。Alpha Teknova 市值為 2.3018 億美元，以其強勁的現金狀況和預期的收入增長而受到關注。Marqeta 的估值為 20.9 億美元，利用其基於雲的 API 平台實現增長，而 Hyliion Holdings 市值為 2.9916 億美元，儘管面臨高波動性和缺乏收入，仍專注於清潔能源技術。文章強調了與這些股票相關的機會和風險</p>

<p>As the U.S. stock market experiences a mixed performance with major indices like the Dow Jones and S&amp;P 500 showing gains, while tech-heavy sectors face challenges, investors are exploring diverse opportunities. Penny stocks, though an older term in investing, continue to represent a segment of smaller or less-established companies that can offer significant value. By focusing on those with strong financial health and potential for growth, investors can discover promising opportunities among these lesser-known stocks.</p>
<div class="lb-trans"><p>隨着美國股市表現參差不齊，道瓊斯指數和標準普爾 500 指數出現上漲，而以科技為主的行業面臨挑戰，投資者正在探索多樣化的機會。雖然 “便士股票” 這一術語在投資中較為陳舊，但它仍然代表了一部分較小或不太成熟的公司，這些公司可能提供顯著的價值。通過關注那些財務健康且具有增長潛力的公司，投資者可以在這些鮮為人知的股票中發現有前景的機會。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美國十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$1.75</td>
<td>$379.32M</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.815</td>
<td>$658.23M</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.745</td>
<td>$588.08M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.95</td>
<td>$1.2B</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Puma Biotechnology (PBYI)</td>
<td>$4.97</td>
<td>$246.41M</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Performance Shipping (PSHG)</td>
<td>$2.2293</td>
<td>$27.72M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.47</td>
<td>$568.6M</td>
<td>✅ 5 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.93</td>
<td>$51.75M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.80</td>
<td>$6.53M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.775</td>
<td>$85.41M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$1.75</td>
<td>$379.32M</td>
<td>✅ 4 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.815</td>
<td>$658.23M</td>
<td>✅ 4 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.745</td>
<td>$588.08M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.95</td>
<td>$1.2B</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Puma Biotechnology (PBYI)</td>
<td>$4.97</td>
<td>$246.41M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Performance Shipping (PSHG)</td>
<td>$2.2293</td>
<td>$27.72M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.47</td>
<td>$568.6M</td>
<td>✅ 5 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.93</td>
<td>$51.75M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.80</td>
<td>$6.53M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.775</td>
<td>$85.41M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 357 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們美國便士股票篩選器的 357 只股票的完整列表。</p>
</div><p>We're going to check out a few of the best picks from our screener tool.</p>
<div class="lb-trans"><p>我們將查看篩選工具中一些最佳選擇。</p>
</div><h2>Alpha Teknova (TKNO)</h2>
<div class="lb-trans"><h2>Alpha Teknova (TKNO)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Alpha Teknova, Inc. produces essential reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics globally with a market cap of $230.18 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Alpha Teknova, Inc. 生產用於全球新療法、疫苗和分子診斷髮現、開發和商業化的基本試劑，市值為 2.3018 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from its Specialty Chemicals segment, which generated $39.80 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入來自其特種化學品部門，該部門產生了 3980 萬美元的收入。</p>
</div><p><strong>Market Cap:</strong> $230.18M</p>
<div class="lb-trans"><p><strong>市值：</strong> $230.18M</p>
</div><p>Alpha Teknova, Inc. is navigating the penny stock landscape with a market cap of US$230.18 million and revenue primarily from its Specialty Chemicals segment, totaling US$39.80 million. The company maintains a strong cash position, covering both short and long-term liabilities, while actively seeking acquisitions to enhance growth and profitability prospects. Despite being unprofitable with increasing losses over the past five years, Teknova's recent earnings report showed improved net loss figures compared to the previous year. Revenue is projected to grow 14.25% annually, though volatility remains high relative to most U.S. stocks.</p>
<div class="lb-trans"><p>Alpha Teknova, Inc. 在便士股票市場中航行，市值為 2.3018 億美元，收入主要來自其特種化學品部門，總計 3980 萬美元。該公司保持強勁的現金狀況，覆蓋短期和長期負債，同時積極尋求收購以增強增長和盈利前景。儘管過去五年虧損不斷增加，但 Teknova 最近的財報顯示淨虧損數字較去年有所改善。預計收入將以每年 14.25% 的速度增長，儘管相對於大多數美國股票，波動性仍然較高。</p>
</div><ul>
<li>Take a closer look at Alpha Teknova's potential here in our financial health report.</li>
<li>Evaluate Alpha Teknova's prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的財務健康報告中更詳細地瞭解 Alpha Teknova 的潛力。</li>
<li>通過訪問我們的收益增長報告評估 Alpha Teknova 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a412f7f5-9a07-448c-9614-8a7f33380346/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/a412f7f5-9a07-448c-9614-8a7f33380346/chart/financial-position-analysis"/></p>
<p>TKNO Financial Position Analysis as at Nov 2025</p>
<div class="lb-trans"><p>TKNO 財務狀況分析截至 2025 年 11 月</p>
</div><h2>Marqeta (MQ)</h2>
<div class="lb-trans"><h2>Marqeta (MQ)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Marqeta, Inc. operates a cloud-based open API platform for card issuing and transaction processing services, with a market cap of approximately $2.09 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Marqeta, Inc. 運營一個基於雲的開放 API 平台，提供卡片發行和交易處理服務，市值約為 20.9 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from its data processing segment, which generated $588.56 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入來自其數據處理部門，該部門產生了 5.8856 億美元的收入。</p>
</div><p><strong>Market Cap:</strong> $2.09B</p>
<div class="lb-trans"><p><strong>市值：</strong> $2.09B</p>
</div><p>Marqeta, Inc., with a market cap of US$2.09 billion, is navigating the penny stock landscape by leveraging its cloud-based API platform for card issuing and transaction processing. Despite being unprofitable, Marqeta has reduced losses over five years and maintains a solid cash runway exceeding three years due to positive free cash flow. The company recently reported third-quarter sales of US$163.31 million with a net loss significantly reduced from the previous year. Collaborations like the expansion of Klarna's card into 15 European markets highlight Marqeta's strategic partnerships and potential for revenue growth, projected at 22% to 24% in Q4 2025.</p>
<div class="lb-trans"><p>Marqeta, Inc. 市值為 20.9 億美元，通過利用其基於雲的 API 平台進行卡片發行和交易處理，正在便士股票市場中航行。儘管處於虧損狀態，Marqeta 在五年內減少了虧損，並保持超過三年的良好現金流。該公司最近報告的第三季度銷售額為 1.6331 億美元，淨虧損顯著低於去年。與 Klarna 的卡片擴展到 15 個歐洲市場等合作，突顯了 Marqeta 的戰略合作伙伴關係和收入增長潛力，預計在 2025 年第四季度增長 22% 至 24%。</p>
</div><ul>
<li>Click here to discover the nuances of Marqeta with our detailed analytical financial health report.</li>
<li>Learn about Marqeta's future growth trajectory here.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏發現 Marqeta 的細微差別，查看我們的詳細分析財務健康報告。</li>
<li>在這裏瞭解 Marqeta 未來的增長軌跡。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/financial-position-analysis"/></p>
<p>MQ Financial Position Analysis as at Nov 2025</p>
<div class="lb-trans"><p>MQ 財務狀況分析截至 2025 年 11 月</p>
</div><h2>Hyliion Holdings (HYLN)</h2>
<div class="lb-trans"><h2>Hyliion Holdings (HYLN)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Hyliion Holdings Corp. designs and develops power generators for stationary and mobile applications, with a market cap of approximately $299.16 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Hyliion Holdings Corp. 設計和開發用於靜態和移動應用的發電機，市值約為 2.9916 億美元。</p>
</div><p><strong>Operations:</strong> Hyliion Holdings Corp. has not reported any specific revenue segments.</p>
<div class="lb-trans"><p><strong>運營：</strong> Hyliion Holdings Corp. 尚未報告任何具體的收入部門。</p>
</div><p><strong>Market Cap:</strong> $299.16M</p>
<div class="lb-trans"><p><strong>市值：</strong> $299.16M</p>
</div><p>Hyliion Holdings, with a market cap of US$299.16 million, is a pre-revenue company focused on innovative power solutions. Despite being unprofitable and reporting a net loss of US$44.01 million for the first nine months of 2025, it has no debt and maintains sufficient cash runway for over a year. The recent successful emissions testing of its KARNO Power Module positions Hyliion at the forefront of clean energy technology, potentially enhancing its commercial prospects across various sectors. However, its high share price volatility and lack of meaningful revenue highlight the inherent risks associated with investing in such early-stage ventures.</p>
<div class="lb-trans"><p>Hyliion Holdings，市值為 2.9916 億美元，是一家專注於創新電力解決方案的無收入公司。儘管處於虧損狀態，並在 2025 年前九個月報告了 4401 萬美元的淨虧損，但它沒有債務，並保持超過一年的現金流。最近成功的 KARNO 電源模塊排放測試使 Hyliion 在清潔能源技術的前沿，可能增強其在各個行業的商業前景。然而，其高股價波動性和缺乏有意義的收入突顯了投資於此類早期階段企業的固有風險。</p>
</div><ul>
<li>Navigate through the intricacies of Hyliion Holdings with our comprehensive balance sheet health report here.</li>
<li>Examine Hyliion Holdings' earnings growth report to understand how analysts expect it to perform.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏通過我們的綜合資產負債表健康報告深入瞭解 Hyliion Holdings。</li>
<li>檢查 Hyliion Holdings 的收益增長報告，以瞭解分析師對其表現的預期。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fb9f2855-7b62-462b-bcd7-cb901c7ca573/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/fb9f2855-7b62-462b-bcd7-cb901c7ca573/chart/financial-position-analysis"/></p>
<p>HYLN Financial Position Analysis as at Nov 2025</p>
<div class="lb-trans"><p>HYLN 財務狀況分析截至 2025 年 11 月</p>
</div><h2>Next Steps</h2>
<div class="lb-trans"><h2>下一步</h2>
</div><ul>
<li>Get an in-depth perspective on all 357 US Penny Stocks by using our screener here.</li>
<li>Want To Explore Some Alternatives? We've found 14 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過使用我們的篩選器，深入瞭解所有 357 只美國便士股票。</li>
<li>想探索一些替代方案嗎？我們發現 14 只預計明年將支付超過 6% 股息收益率的美國股票。查看完整列表，免費獲取。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章不應被視為財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div>

Alpha Teknova 是值得關注的三隻便士股票之一